Introduction of Some Newly Launched Sequencers (1)

December 14, 2018

MGI Launches Innovative ULTRA-HIGH-THROUGHPUT Genetic Sequencer, MGISEQ-T7

Oct. 27, 2018--MGI, a subsidiary of BGI Group, introduced its newest model of genetic sequencer, MGISEQ-T7, which vastly improves speed, throughput and flexibility, at the 13th International Conference on Genomics (ICG-13) in Shenzhen. The most powerful MGI sequencer to date, MGISEQ-T7 is built with innovative quadruple flow-cell staging that allows simultaneous but independent operation of 1 to 4 flow cells in a single run. The MGI proprietary technology used in T7 delivers higher accuracy and improves efficiency through upgrades to the flow cell, fluid, and biochemical and optical system. A supercomputer for the life science industry, MGISEQ-T7 takes the production capacity of the sequencer to a new level with daily output of data up to 6Tb.

The MGISEQ-T7's innovations include:

  1. Unique Quad-Flowcell Platform, supporting independent operation of 1-4 chips

    A revolutionary quad-flow cell platform enables multiple flow cells with different read lengths and applications to be processed independently at any time in a single run. The platform supports whole genome sequencing, ultra-depth exome sequencing, epigenome sequencing, and large-panel tumor gene detection.

  2. Sequencing speed increased by over 50%

    MGISEQ-T7 runs much faster than any other sequencer to date. PE150 takes less than 24 hours at full load to complete.

  3. Single chip density increased by 20%

    MGISEQ-T7's chip density is increased by 20%. Terabyte-level data can be produced with a single chip.

The ultra-fast, ultra-high-throughput MGISEQ-T7 can complete WGS for up to 60 human genomes in a single day, breaking barriers for what a next generation sequencer can do. MGISEQ-T7 accelerates the development of nationwide genomics projects, since a T7 can complete the sequencing of 10,000 genomes within a year.

For research purposes only, not intended for clinical diagnosis, treatment, or individual health assessments.
PDF Download
* Email Address:

CD Genomics needs the contact information you provide to us in order to contact you about our products and services and other content that may be of interest to you. By clicking below, you consent to the storage and processing of the personal information submitted above by CD Genomcis to provide the content you have requested.

×
Quote Request
! For research purposes only, not intended for clinical diagnosis, treatment, or individual health assessments.
Contact CD Genomics
  • SUITE 111, 17 Ramsey Road, Shirley, NY 11967, USA
  • 1-631-338-8059
  • 1-631-614-7828
Terms & Conditions | Privacy Policy | Feedback   Copyright © 2025 CD Genomics. All rights reserved.
Top

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x